Middle East and Africa Adalimumab Market Gains Momentum Amid Rising Autoimmune Disease Prevalence
"Executive Summary Middle East and Africa Adalimumab Market Size and Share Analysis Report CAGR Value Data Bridge Market Research analyses that the Middle East and Africa adalimumab market was valued at USD 134.81 million in 2021 and is expected to reach USD 181.68 million by 2029, registering a CAGR of 3.80% during the forecast period of 2022 to 2029. the Middle East and Africa...
0 Commentarii 0 Distribuiri 10 Views 0 previzualizare
Sponsor
Sponsor
Sponsor